Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease. Patel BM, Ramos Rivers C, Koutroumpakis F, Ahsan M, et al. Inflamm Bowel Dis 2021;27:e124.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Patel BM, Ramos Rivers C, Koutroumpakis F, Ahsan M, et al. Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease. Inflamm Bowel Dis 2021;27:e124.
PMID: 33999193